๐ข ๐๐จ๐ฆ๐ง ๐๐ก: $Eli Lilly(LLY.US) Eli Lilly and Resilience Invest $๐ณ๐ฑ๐ฌ ๐ ๐ถ๐น๐น๐ถ๐ผ๐ป to Expand U.S. Drug Manufacturing
๐ ๐๐ฒ๐ ๐๐ถ๐ด๐ต๐น๐ถ๐ด๐ต๐๐:โค ๐๐น๐ถ ๐๐ถ๐น๐น๐ and ๐ฅ๐ฒ๐๐ถ๐น๐ถ๐ฒ๐ป๐ฐ๐ฒ will invest $๐ณ๐ฑ๐ฌ ๐บ๐ถ๐น๐น๐ถ๐ผ๐ป in U.S. manufacturing.โค Investment will create ๐ฐ๐ฌ๐ฌ new high-skilled jobs in Cincinnati, Ohio.โค Resilience will manufacture ๐๐ถ๐น๐น๐'๐ ๐๐๐ถ๐ธ๐ฃ๐ฒ๐ป injectable devices.โค KwikPen supports treatments for ๐ฑ๐ถ๐ฎ๐ฏ๐ฒ๐๐ฒ๐ and ๐ผ๐ฏ๐ฒ๐๐ถ๐๐.โค Partnership has produced over ๐ญ๐ฑ๐ฌ ๐บ๐ถ๐น๐น๐ถ๐ผ๐ป medicine doses since ๐ฎ๐ฌ๐ฎ๐ฏ.โค Lilly's U.S. capital expansion commitments exceed $๐ฑ๐ฑ ๐ฏ๐ถ๐น๐น๐ถ๐ผ๐ป since ๐ฎ๐ฌ๐ฎ๐ฌ.โค Lilly plans to begin construction at additional U.S. manufacturing sites this year.โค Investment comes amid broader industry efforts to expand U.S. pharmaceutical production.๐ ๐ช๐ต๐ ๐ง๐ต๐ถ๐ ๐ ๐ฎ๐๐๐ฒ๐ฟ๐:โค Expands manufacturing capacity for Lilly's fast-growing diabetes and obesity medicines.โค Strengthens domestic pharmaceutical supply chains amid evolving U.S. trade policies.โค Reinforces Lilly's long-term manufacturing strategy to meet rising patient demand.โค Highlights continued reshoring of drug production across the pharmaceutical industry.๐ ๐๐ ๐ฝ๐ฒ๐ฟ๐ ๐ฆ๐๐ฎ๐๐ฒ๐บ๐ฒ๐ป๐:๐๐ฑ๐ด๐ฎ๐ฟ๐ฑ๐ผ ๐๐ฒ๐ฟ๐ป๐ฎ๐ป๐ฑ๐ฒ๐, Lilly's Manufacturing Head:"The partnership reflects Lilly's efforts to meet rising demand for its medicines."The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments